Home
Avalyn Pharma AVLN paid Dla Piper $60K for lobbying in Q1 2026 · Medical, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q1 2026
- Stock
- Avalyn Pharma AVLN
- Client
- Avalyn Pharma
- Reported
- 26/04/16
Up 50.0% from last quarter
What else happened in Avalyn Pharma around then
Filed or reported within 30 days of the trade day · 03/01~04/30Avalyn Pharma's other lobbying reports
- Avalyn Pharma
LobbyingAvalyn Pharma
LobbyingAvalyn Pharma
AVLN
$60K
$60K
Reported 07/17
for Q2
- Avalyn Pharma
LobbyingAvalyn Pharma
LobbyingAvalyn Pharma
AVLN
$40K
$40K
Reported 01/16
for Q4 2025